Contact Us
Inactivated Polio And Rabies Vaccines Global Market Report 2025
Global Inactivated Polio And Rabies Vaccines Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Inactivated Polio And Rabies Vaccines Global Market Report 2025

By Product Type (Inactivated Polio Vaccine, Inactivated Rabies Vaccine), By Method Of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations), By Distribution Channel (Government, Private), By Application (Pediatrics, Adults) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Inactivated Polio And Rabies Vaccines Market Overview

• Inactivated Polio And Rabies Vaccines market size has reached to $2.16 billion in 2024

• Expected to grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: The Growing Demand For Effective Vaccination Programs Is Fueling The Growth Of The Market Due To Increasing Government Efforts And Global Health Initiatives

• Market Trend: Advancement In Inactivated Rabies Vaccines Enhances Global Disease Prevention Efforts

North America was the largest region in 2024.

What Is Covered Under Inactivated Polio And Rabies Vaccines Market?

Inactivated polio and rabies vaccines (IPV) are designed to protect individuals from polio and rabies, respectively. Both vaccines are created using viruses that have been killed, ensuring they cannot cause disease. IPV prevents poliomyelitis, a viral condition that can lead to paralysis, while the inactivated rabies vaccine safeguards against rabies, a deadly infection typically transmitted through animal bites. These vaccines stimulate the immune system to provide durable protection without inducing illness.

The main product types of inactivated polio and rabies vaccines are inactivated polio vaccine and inactivated rabies vaccine. Inactivated polio vaccine (IPV) is a safe, injected vaccine derived from inactivated poliovirus, used to boost immunity and protect against polio without causing infection. It is inactivated by using various methods, such as the solvent detergent method, radiation method, pH concentration, heat inactivation, and others, and is distributed through several distribution channels, including government and private, for different applications, including pediatrics and adults.

Inactivated Polio And Rabies Vaccines Market Size and growth rate 2025 to 2029: Graph

What Is The Inactivated Polio And Rabies Vaccines Market Size 2025 And Growth Rate?

The inactivated polio and rabies vaccines market size has grown strongly in recent years. It will grow from $2.16 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing vaccination campaigns, rising awareness about polio and rabies, government immunization programs, high incidence rates of polio and rabies in certain regions, and support from international health organizations.

What Is The Inactivated Polio And Rabies Vaccines Market Growth Forecast?

The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to advancements in vaccine technology, growing demand for vaccination in emerging markets, increased focus on global health security, government policies promoting vaccination, rising healthcare expenditure on preventive measures, etc. Major trends in the forecast period include increasing demand for combined polio and rabies vaccines, advancements in freeze-drying technology for vaccine stability, development of single-dose formulations for easier administration, advancements in cold chain logistics for improved vaccine distribution, growth in global immunization programs, and government-funded vaccination initiatives.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Import restrictions could challenge vaccination programs by increasing prices of combination inactivated viral vaccines manufactured in the Netherlands and South Korea, potentially reducing immunization coverage and raising public health costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Inactivated Polio And Rabies Vaccines Market Segmented?

1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine

2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations

3) By Distribution Channel: Government, Private

4) By Application: Pediatrics, Adults

Subsegments:

1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine

2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine

What Is Driving The Inactivated Polio And Rabies Vaccines Market? The Growing Demand For Effective Vaccination Programs Is Fueling The Growth Of The Market Due To Increasing Government Efforts And Global Health Initiatives

The growing demand for effective vaccination programs is expected to propel the growth of the inactivated polio and rabies vaccines going forward. A vaccination program is a planned effort by a group or government to give people vaccines to help protect them from diseases. Rising vaccination programs stem from stronger government efforts to prevent outbreaks, lower healthcare costs, and boost public health. Vaccination programs boost demand for inactivated polio and rabies vaccines by enhancing awareness, funding, and coverage in high-risk areas. Mass campaigns and routine immunizations led by governments and health bodies sustain consistent uptake. For instance, in April 2024, according to the Pan American Health Organization (PAHO), a US-based specialized agency, the 22nd Vaccination Week in the Americas (VWA) with the theme Engage now to protect your future GetVax launched, aiming to increase vaccination coverage, especially in underserved areas, by administering over 65 million doses. The initiative focused on combating misinformation and enhancing access to vaccines through community engagement and tailored campaigns. Therefore, the growing demand for effective vaccination programs is driving the growth of the inactivated polio and rabies vaccines industry.

Who Are The Major Players In The Global Inactivated Polio And Rabies Vaccines Market?

Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.

What Are The Key Trends Of The Global Inactivated Polio And Rabies Vaccines Market? Advancement In Inactivated Rabies Vaccines Enhances Global Disease Prevention Efforts

Major companies operating in the inactivated polio and rabies vaccines market are focused on developing advanced products, such as killed virus rabies vaccines, to improve immunogenicity and meet the rising global demand for effective disease prevention. Killed virus rabies vaccines are formulated using rabies virus that has been rendered non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without causing the disease, ensuring safety and effectiveness in both pre- and post-exposure prophylaxis. For instance, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for pre-exposure and post-exposure prophylaxis of rabies in all age groups. The vaccine, licensed in the UK based on extensive clinical data from over 13,000 individuals, has been widely used in more than 80 countries. Verorab provides an effective immunization option for travelers to high-risk countries and for treatment after rabies exposure, with clinical trials showing strong immune responses and long-lasting protection.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Inactivated Polio And Rabies Vaccines Market? Sanofi Partnered With Biovac To Boost Local Inactivated Polio Vaccine Production In Africa

In June 2024, Sanofi, a France-based manufacturer of inactivated polio vaccine, partnered with Biovac to empower Africa through local vaccine production. The partnership aims to establish sustainable local manufacturing of inactivated polio vaccines (IPV) in Africa, strengthen regional self-sufficiency, and support polio eradication efforts across over 40 African countries. Biovac is a South Africa-based biopharmaceutical company that specializes in developing vaccines for diseases that affect people in Africa.

What Is The Regional Outlook For The Global Inactivated Polio And Rabies Vaccines Market?

North America was the largest region in the inactivated polio and rabies vaccines market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inactivated Polio And Rabies Vaccines Market?

The inactivated polio and rabies vaccines market consists of sales of combination vaccines containing inactivated polio vaccine (IPV), pre-exposure prophylaxis vaccines, and post-exposure prophylaxis (PEP) kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold to the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Inactivated Polio And Rabies Vaccines Industry?

The inactivated polio and rabies vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inactivated polio and rabies vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Inactivated Polio And Rabies Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.27 billion
Revenue Forecast In 2034 $2.81 billion
Growth Rate CAGR of 5.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The inactivated polio and rabies vaccines market covered in this report is segmented –
1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations
3) By Distribution Channel: Government, Private
4) By Application: Pediatrics, Adults Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Inactivated Polio And Rabies Vaccines Market Characteristics

3. Inactivated Polio And Rabies Vaccines Market Trends And Strategies

4. Inactivated Polio And Rabies Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Inactivated Polio And Rabies Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Inactivated Polio And Rabies Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Inactivated Polio And Rabies Vaccines Market Growth Rate Analysis

5.4. Global Inactivated Polio And Rabies Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Inactivated Polio And Rabies Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Inactivated Polio And Rabies Vaccines Total Addressable Market (TAM)

6. Inactivated Polio And Rabies Vaccines Market Segmentation

6.1. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inactivated Polio Vaccine

Inactivated Rabies Vaccine

6.2. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solvent Detergent Method

Radiation Method

pH Concentration

Heat Inactivation

Other Method Of Inactivations

6.3. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Government

Private

6.4. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatrics

Adults

6.5. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Polio Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Inactivated Polio Vaccine

Oral Inactivated Polio Vaccine

6.6. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Rabies Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Inactivated Rabies Vaccine

Intradermal Inactivated Rabies Vaccine

7. Inactivated Polio And Rabies Vaccines Market Regional And Country Analysis

7.1. Global Inactivated Polio And Rabies Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Inactivated Polio And Rabies Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inactivated Polio And Rabies Vaccines Market

8.1. Asia-Pacific Inactivated Polio And Rabies Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inactivated Polio And Rabies Vaccines Market

9.1. China Inactivated Polio And Rabies Vaccines Market Overview

9.2. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inactivated Polio And Rabies Vaccines Market

10.1. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inactivated Polio And Rabies Vaccines Market

11.1. Japan Inactivated Polio And Rabies Vaccines Market Overview

11.2. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inactivated Polio And Rabies Vaccines Market

12.1. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inactivated Polio And Rabies Vaccines Market

13.1. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inactivated Polio And Rabies Vaccines Market

14.1. South Korea Inactivated Polio And Rabies Vaccines Market Overview

14.2. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inactivated Polio And Rabies Vaccines Market

15.1. Western Europe Inactivated Polio And Rabies Vaccines Market Overview

15.2. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inactivated Polio And Rabies Vaccines Market

16.1. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inactivated Polio And Rabies Vaccines Market

17.1. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inactivated Polio And Rabies Vaccines Market

18.1. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inactivated Polio And Rabies Vaccines Market

19.1. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inactivated Polio And Rabies Vaccines Market

20.1. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inactivated Polio And Rabies Vaccines Market

21.1. Eastern Europe Inactivated Polio And Rabies Vaccines Market Overview

21.2. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inactivated Polio And Rabies Vaccines Market

22.1. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inactivated Polio And Rabies Vaccines Market

23.1. North America Inactivated Polio And Rabies Vaccines Market Overview

23.2. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inactivated Polio And Rabies Vaccines Market

24.1. USA Inactivated Polio And Rabies Vaccines Market Overview

24.2. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inactivated Polio And Rabies Vaccines Market

25.1. Canada Inactivated Polio And Rabies Vaccines Market Overview

25.2. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inactivated Polio And Rabies Vaccines Market

26.1. South America Inactivated Polio And Rabies Vaccines Market Overview

26.2. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inactivated Polio And Rabies Vaccines Market

27.1. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inactivated Polio And Rabies Vaccines Market

28.1. Middle East Inactivated Polio And Rabies Vaccines Market Overview

28.2. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inactivated Polio And Rabies Vaccines Market

29.1. Africa Inactivated Polio And Rabies Vaccines Market Overview

29.2. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inactivated Polio And Rabies Vaccines Market Competitive Landscape And Company Profiles

30.1. Inactivated Polio And Rabies Vaccines Market Competitive Landscape

30.2. Inactivated Polio And Rabies Vaccines Market Company Profiles

30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sinovac Biotech Overview, Products and Services, Strategy and Financial Analysis

31. Inactivated Polio And Rabies Vaccines Market Other Major And Innovative Companies

31.1. Zoetis Inc.

31.2. Cadila Pharmaceuticals

31.3. Zydus Lifesciences Limited

31.4. Biological E. Limited

31.5. Serum Institute of India (SII)

31.6. Indian Immunologicals Limited (IIL)

31.7. Instituto Butantan

31.8. Valneva SE

31.9. Bio Farma

31.10. Bharat Biotech

31.11. Bilthoven Biologicals

31.12. Panacea Biotec

31.13. Batavia Biosciences

31.14. Hilleman Laboratories

31.15. China National Pharmaceutical Group Co Ltd.

32. Global Inactivated Polio And Rabies Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inactivated Polio And Rabies Vaccines Market

34. Recent Developments In The Inactivated Polio And Rabies Vaccines Market

35. Inactivated Polio And Rabies Vaccines Market High Potential Countries, Segments and Strategies

35.1 Inactivated Polio And Rabies Vaccines Market In 2029 - Countries Offering Most New Opportunities

35.2 Inactivated Polio And Rabies Vaccines Market In 2029 - Segments Offering Most New Opportunities

35.3 Inactivated Polio And Rabies Vaccines Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Polio Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Rabies Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Inactivated Polio And Rabies Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Inactivated Polio And Rabies Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Merck & Co Inc. Financial Performance
  • Table 78: Sanofi S.A. Financial Performance
  • Table 79: LG Chem Ltd. Financial Performance
  • Table 80: Boehringer Ingelheim International GmbH Financial Performance
  • Table 81: Sinovac Biotech Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Polio Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Rabies Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Inactivated Polio And Rabies Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Inactivated Polio And Rabies Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Merck & Co Inc. Financial Performance
  • Figure 78: Sanofi S.A. Financial Performance
  • Figure 79: LG Chem Ltd. Financial Performance
  • Figure 80: Boehringer Ingelheim International GmbH Financial Performance
  • Figure 81: Sinovac Biotech Financial Performance

Frequently Asked Questions

Inactivated polio and rabies vaccines (IPV) are designed to protect individuals from polio and rabies, respectively. Both vaccines are created using viruses that have been killed, ensuring they cannot cause disease. IPV prevents poliomyelitis, a viral condition that can lead to paralysis, while the inactivated rabies vaccine safeguards against rabies, a deadly infection typically transmitted through animal bites. These vaccines stimulate the immune system to provide durable protection without inducing illness. For further insights on this market, request a sample here

The market major growth driver - The Growing Demand For Effective Vaccination Programs Is Fueling The Growth Of The Market Due To Increasing Government Efforts And Global Health Initiatives. For further insights on this market, request a sample here

The inactivated polio and rabies vaccines market size has grown strongly in recent years. It will grow from $2.16 billion in 2024 to $2.27 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing vaccination campaigns, rising awareness about polio and rabies, government immunization programs, high incidence rates of polio and rabies in certain regions, and support from international health organizations. The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to " $2.81 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to advancements in vaccine technology, growing demand for vaccination in emerging markets, increased focus on global health security, government policies promoting vaccination, rising healthcare expenditure on preventive measures, etc. Major trends in the forecast period include increasing demand for combined polio and rabies vaccines, advancements in freeze-drying technology for vaccine stability, development of single-dose formulations for easier administration, advancements in cold chain logistics for improved vaccine distribution, growth in global immunization programs, and government-funded vaccination initiatives. For further insights on this market, request a sample here

The inactivated polio and rabies vaccines market covered in this report is segmented –
1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations
3) By Distribution Channel: Government, Private
4) By Application: Pediatrics, Adults Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine For further insights on this market,
request a sample here

North America was the largest region in the inactivated polio and rabies vaccines market in 2024. The regions covered in the inactivated polio and rabies vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Advancement In Inactivated Rabies Vaccines Enhances Global Disease Prevention Efforts. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon